Predicta Med’s data-driven insights platform, PredictAITM, aims to improve the quality of care for patients with immune-related conditions and reduce healthcare costs by assisting health professionals to identify these diseases in advance of current standards. The EMR-integrated solution can assist providers in identifying individuals with undiagnosed immune-related conditions and enabling targeted interventions earlier in the course of the disease to help mitigate disease-related deterioration and complications.

To date, the models have been trained and validated on more than 7M electronic medical

patient records and 1.7M claims records

Predicta Med is transforming the care of autoimmune diseases by offering an EMR-integrated platform that accelerates diagnosis and intervention. The platform includes three core modules:

• PredictaAI: The first AI-driven solution designed for early detection and tailored intervention of autoimmune diseases, enhancing diagnostic accuracy and speed.
• PredictaChart: The tool streamlines clinical decision-making, significantly reducing the time spent on patient chart reviews.
• PredictaMatch: A patient eligibility assessment tool, seamlessly embedded in EMRs, providing healthcare providers with relevant treatment options based on a patient’s disease profile.

Together, these modules enable faster, more accurate care decisions, improving outcomes for patients with autoimmune diseases

Web-based clinical intelligence platform, primarily utilized in critical care units to guide clinical decisions. The platform has full interoperability with the Electronic Health Record, and combines all relevant data within the complex critical care environment into one visualization to provide a full picture of a patient and their longitudinal trends. FDA-cleared algorithms continually assess the incoming patient information and provide early warning signs of clinical deterioration to aid care teams with determining interventions and treatment. Automated clinical workflows, customized to each individual ICU, provide care efficiency and positively impact clinical outcomes. 

Published clinical outcomes showing:

• Up to 36% reduction in ICU length of stay
• 41% reduction in ICU readmissions
• 22% reduction in time on ventilation
• 18% reduction in time on vasoactive medication

Commercial stage company with market leading AI clinical decision support platform for bedside and remote monitoring of high acuity patients. Published outcomes and strong ROI; utilized in 40+ hospitals & health systems.

Predictive diagnostics using AI - Using patient data to anticipate immune-related potential health risks and improve patient care.

Effective intervention- Eenabling targeted interventions earlier in the course of the disease to help mitigate disease-related deterioration and complications.

Trained & validated on proprietary, large data sets

Domain expertise in immune-related diseases and specialty care 

Established partnerships with global experts providers

Seamless EMR workflow integration  

Etiometry provides functionality to seamlessly extend the EHR to be effective for care in high-acuity patient settings (e.g. ICU), including automating clinical workflows, and providing in-depth, longitudinal trends.

Etiometry is the only CDS platform with 4 FDA-cleared risk algorithms and the platform's data collection capabilities have led to a vastly larger number of supporting clinical studies (>150).